Neoadjuvant treatment: the future of patients with breast cancer

por Reyal, F, Hamy, AS, Piccart, Martine J
Publicado 2018

Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based models

por Laas, E, Mallon, P, Delomenie, M, Gardeux, V, Pierga, J-Y, Cottu, P, Lerebours, F, Stevens, D, Rouzier, R, Reyal, F
Publicado 2015

Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma

por Rossi, L, Laas, E, Mallon, P, Vincent-Salomon, A, Guinebretiere, J-M, Lerebours, F, Rouzier, R, Pierga, J-Y, Reyal, F
Publicado 2015

Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy

por Baulies, S, Belin, L, Mallon, P, Senechal, C, Pierga, J-Y, Cottu, P, Sablin, M-P, Sastre, X, Asselain, B, Rouzier, R, Reyal, F
Publicado 2015

Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay

por Mouttet, D., Laé, M., Caly, M., Gentien, D., Carpentier, S., Peyro-Saint-Paul, H., Vincent-Salomon, A., Rouzier, R., Sigal-Zafrani, B., Sastre-Garau, X., Reyal, F.
Publicado 2016

Axillary lymph node micrometastases decrease triple-negative early breast cancer survival

por Houvenaeghel, G, Sabatier, R, Reyal, F, Classe, J M, Giard, S, Charitansky, H, Rouzier, R, Faure, C, Garbay, J R, Daraï, E, Hudry, D, Gimbergues, P, Villet, R, Lambaudie, E
Publicado 2016

A multivariate Th17 metagene for prognostic stratification in T cell non-inflamed triple negative breast cancer

por Faucheux, L., Grandclaudon, M., Perrot-Dockès, M., Sirven, P., Berger, F., Hamy, A.S., Fourchotte, V., Vincent-Salomon, A., Mechta-Grigoriou, F., Reyal, F., Scholer-Dahirel, A., Guillot-Delost, M., Soumelis, V.
Publicado 2019

Cytochrome P-450-mediated herb and food–drug interactions can be identified in cancer patients through patient self-reporting with a tablet application: results of a prospective ob...

por Gougis, P., Géraud, A., Hilmi, M., Vozy, A., Campedel, L., Abbar, B., Allio, C., De Chatillon, S., Portalier, A., Lapray, F., Choquet, S., Spano, J.-P., Reyal, F., Mir, O., Funck-Brentano, C., Hamy, A.-S.
Publicado 2022

Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma

por Daveau, C, Baulies, S, Lalloum, M, Bollet, M, Sigal-Zafrani, B, Sastre, X, Vincent-Salomon, A, Tardivon, A, Thibault, F, Pierga, J Y, Cottu, P, Sablin, M P, Rouzier, R, Malhaire, C, Mallon, P, Reyal, F
Publicado 2014

Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort(☆)

por Houvenaeghel, G., de Nonneville, A., Cohen, M., Chopin, N., Coutant, C., Reyal, F., Mazouni, C., Gimbergues, P., Azuar, A.-S., Chauvet, M.-P., Classe, J.-M., Daraï, E., Martinez, A., Rouzier, R., de Lara, C.T., Lambaudie, E., Barrou, J., Goncalves, A.
Publicado 2021

Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study

por Houvenaeghel, G., Cohen, M., Classe, J.M., Reyal, F., Mazouni, C., Chopin, N., Martinez, A., Daraï, E., Coutant, C., Colombo, P.E., Gimbergues, P., Chauvet, M.P., Azuar, A.S., Rouzier, R., Tunon de Lara, C., Muracciole, X., Agostini, A., Bannier, M., Charaffe Jauffret, E., De Nonneville, A., Goncalves, A.
Publicado 2021